Keros Therapeutics, Inc. · NASDAQ:KROS
JPMorgan Chase & Co's stake in Keros Therapeutics, Inc. fell to 0.20% (Schedule 13G/A)
Event Apr 30, 2025 · Filed May 5, 2025
JPMorgan Chase & Co's stake in Keros Therapeutics, Inc. fell to 0.20%, 113,803 shares, as a passive investor on Apr 30, 2025. Filed May 5, 2025 (Schedule 13G/A).
- Stake
- 0.20%
- Shares
- 113,803
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JPMORGAN CHASE & CO. | 0.20% | 113,803 |
Source
Related
- Keros Therapeutics, Inc.
- JPMorgan Chase & Co
- Keros Therapeutics, Inc. shareholders
- Schedule 13G · JPMorgan Chase & Co · May 2, 2025
- Form 4 · Tanini Annita · Aug 20, 2026
- Form 4 · Lerner Lorena Raquel · Aug 20, 2026
- Form 4 · Cho Esther · Aug 20, 2026
- Form 4 · Newton Charles W. · Aug 20, 2026
- Form 4 · Bienaime Jean Jacques · Aug 19, 2026